<p>Section I--Etiology</p><p>1. The Genetics of Narcolepsy</p><p>2. Orexin (Hypocretin) and Narcolepsy</p><p>3. Precipitants of Narcolepsy: Vaccines and Infections</p><p>Section II--Clinical Considerations</p><p>4. Epidemiology of Narcolepsy</p><p>5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy</p><p>6. Narcolepsy in Childhood</p><p>7. Narcolepsy in the Older Adult</p><p>8. Hypnagogic Hallucinations and Sleep Paralysis</p><p>9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency</p><p>10. Hypersomnias Other than Narcolepsy:</p> Differential Diagnosis<p></p><p>11. Narcolepsy and Other Comorbid Medical Illnesses</p><p>12. Sleep Disorders Comorbidities in Narcolepsy and their Management</p><p>13. Neuroimaging of Narcolepsy</p><p>Section III--Psychosocial Considerations</p><p>14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management</p><p>15. Narcolepsy, Intimacy and Sexuality</p><p>16. Memory and Cognition in Narcolepsy</p><p>17. Psychoanalysis and Narcolepsy</p><p>18. Dreaming in Narcolepsy</p><p>19. Narcolepsy and Mental Illness</p><p>20. Narcolepsy, Driving and Traffic Safety</p><p>Section IV--Management</p>21. Overview of Management of Narcolepsy<p></p><p>22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics</p><p>23. Modafinil/Armodafinil in the Treatment of N</p><p></p><p></p>arcolepsy<p></p><p>24. Sodium Oxybate in the Treatment of Narcolepsy</p><p>25. Pregnancy and Anaesthesia in Narcolepsy</p><p>26. Emerging Treatments for Narcolepsy</p><p>27. Behavioral and Non-Pharmacological Management of Narcolepsy</p><p>Section V--Health Care Delivery and Medico-Legal Considerations</p><p>28. Narcolepsy and Developmental Disability</p><p>29. Succeeding in School and in the Workplace with Narcolepsy</p><p>30. Medico-Legal Aspects of Disability in Narcolepsy</p>31. The Affordable Care Act and the Future of Sleep Medicine<p></p>